The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

Quest Diagnostics Declares Quarterly Cash Dividend

Tuesday, February 26, 2013

Quest Diagnostics Declares Quarterly Cash Dividend16:41 EST Tuesday, February 26, 2013MADISON, N.J., Feb. 26, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.30 per share, payable on April 16, 2013, to shareholders of record of Quest Diagnostics common stock on April 2, 2013. About Quest DiagnosticsQuest Diagnostics is the world's leading provider of diagnostic information services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic information services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at Follow us at and Diagnostics Contacts:Dan Haemmerle (Investors): 973-520-2900Wendy Bost (Media): 973-520-2800SOURCE Quest Diagnostics